Application of myeloid growth factors in the treatment of acute myeloid leukemia
✍ Scribed by Terpstra, W; Löwenberg, B
- Book ID
- 110053419
- Publisher
- Nature Publishing Group
- Year
- 1997
- Tongue
- English
- Weight
- 161 KB
- Volume
- 11
- Category
- Article
- ISSN
- 0887-6924
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Significant progress in understanding the mechanisms leading to the development of acute myeloid leukemia (AML) has led to the identification of numerous molecular abnormalities that may be responsible for leukemogenesis. Over the same period, large trials have established standard regi
## Abstract Gemtuzumab ozogamicin (GO) is a chemotherapeutic agent that consists of a humanized anti‐CD33 antibody (hP67.6) linked to N‐acetyl‐γ calicheamicin 1,2‐dimethyl hydrazine dichloride, a potent enediyne antitumor antibiotic. GO was approved conditionally by the Federal Drug Administration